Title : Upregulation of GRIM-19 augments the sensitivity of prostate cancer cells to docetaxel by targeting Rad23b.

Pub. Date : 2020 Jan

PMID : 31531888






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Upregulation of GRIM-19 augments the sensitivity of prostate cancer cells to docetaxel by targeting Rad23b. Docetaxel NADH:ubiquinone oxidoreductase subunit A13 Homo sapiens
2 This study aims to clarify the potential role and molecular mechanisms of GRIM-19 on the response of PC cells to chemical drug docetaxel. Docetaxel NADH:ubiquinone oxidoreductase subunit A13 Homo sapiens
3 Knockdown of GRIM-19 increased the resistance of PC cells to docetaxel, and overexpression of GRIM-19 promoted docetaxel-induced apoptotic death in PC cells. Docetaxel NADH:ubiquinone oxidoreductase subunit A13 Homo sapiens
4 Knockdown of GRIM-19 increased the resistance of PC cells to docetaxel, and overexpression of GRIM-19 promoted docetaxel-induced apoptotic death in PC cells. Docetaxel NADH:ubiquinone oxidoreductase subunit A13 Homo sapiens
5 overexpression of Rad23b reversed GRIM-19-mediated response to docetaxel in PC cells. Docetaxel NADH:ubiquinone oxidoreductase subunit A13 Homo sapiens
6 GRIM-19 promoted the sensitivity of PC cells to docetaxel by downregulating Rad23b, which may serve as a promising target to develop a better strategy of chemotherapy for PC. Docetaxel NADH:ubiquinone oxidoreductase subunit A13 Homo sapiens